Breast ultrasound imaging developer TechniScan has closed on the first $1.85 million of a proposed $2.5 million in bridge financing.
The lead investor was Biotex Pharma Investments, with additional participation from TechniScan directors and shareholders, according to the Salt Lake City-based firm. The funding, which will be structured as convertible debt, will be used to continue TechniScan's growth and development plans, TechniScan said.
Related Reading
TechniScan begins phase II warm bath US study, March 9, 2010
TechniScan, Esaote renew OEM deal, December 18, 2009
TechniScan adds Pepper to board, December 17, 2009
TechniScan hires CFO, November 11, 2009
Copyright © 2010 AuntMinnie.com